VACCINES FOR CLASSIC SEXUALLY-TRANSMITTED DISEASES

Sexually transmitted diseases (STDs) can substantially increase the mo rbidity and mortality of exposed adults and children. Despite the adve nt of new antibiotics and focus on behavioral interventions such as co ndom use, attempts to limit the spread of STDs have been largely unsuc cessful. Vaccines have received increasing attention as a potential st rategy for STD control. This article focuses on the current status of vaccine research for five classic STDs: gonorrhea, genital herpes, syp hilis, chancroid and chlamydia.